May 24, 2016
The visible impacts of depression and stress that can be seen in a person's face -- and contribute to shorter lives -- can also be found in alterations in genetic activity, according to newly published research.
Biotech startup based on IU School of Medicine research launches to develop therapy for lung diseaseMay 13, 2016
Indiana University Research and Technology Corp. has optioned technology to biotech startup Allinaire Therapeutics that could treat patients affected by lung-related diseases.
May 6, 2016
The hard work put in by 418 future physicians and scientists will be recognized Saturday when the IU School of Medicine holds its annual commencement ceremonies at 10 a.m. in the Sagamore Ballroom of the Indiana Convention Center.
May 5, 2016
Use of hospice services does not increase care costs in the last six months of life for long-stay nursing homes residents.
Chuckstrong Tailgate Gala sets record with nearly $1.2 million for cancer research at IU Simon Cancer CenterApril 22, 2016
The fourth annual Chuckstrong Tailgate Gala set a record Thursday night with nearly $1.2 million netted for cancer research at the Indiana University Melvin and Bren Simon Cancer Center.
April 21, 2016
IU researchers find that existing algorithms and open source machine learning tools are as good as, or better than, human reviewers in detecting cancer cases using data from free-text pathology reports.
April 19, 2016
A new study from the Indiana University Center for Aging Research and the Regenstrief Institute has found that almost half of all long-stay nursing home residents experience at least one transfer to an Emergency Department over the course of a year regardless of their cognitive status.
April 18, 2016
Older adults might want to avoid a using class of drugs commonly used in over-the-counter products such as nighttime cold medicines due to their links to cognitive impairment, a research team led by scientists at Indiana University School of Medicine. Using brain imaging techniques, the researchers found lower metabolism and reduced brain sizes among study participants taking the drugs known to have an anticholinergic effect, meaning they block acetylcholine, a nervous system neurotransmitter.